Since its outbreak in December 2019, the COVID-19 pandemic has caused the death of
more than 6.5 million people around the world. The high transmissibility of its causative …

Background. Since the beginning of the novel coronavirus (SARS‐CoV‐2) disease
outbreak, there has been an increasing interest in discovering potential therapeutic agents …

The COVID-19 pandemic has motivated researchers all over the world in trying to find
effective drugs and therapeutics for treating this disease. To save time, much effort has …

The rapid spread of SARS-CoV-2 and the resulting pandemic has led to a spasmodic search
for approaches able to limit the diffusion of the disease. The epigenetic machinery has …

The COVID-19 pandemic has had a devastating impact worldwide and has been a great
challenge for the scientific community. Vaccines against SARS-CoV-2 are now efficiently …

Microplastics (MP) pollution is a global issue that raises concerns about potential toxicity for
environmental and human health. The notion that SARS-CoV-2 is more stable when …

Currently, various potential therapeutic agents for coronavirus disease-2019 (COVID-19), a
global pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS …

Background Despite the significant progress achieved in understanding the pathology and
clinical management of SARS-CoV-2 infection, still pathogenic and clinical issues need to …

A significant number of SARS-CoV-2-infected individuals naturally overcome viral infection,
suggesting the existence of a potent endogenous antiviral mechanism. As an innate defense …

The SARS-CoV-2 virus is responsible for COVID-19 affecting millions of humans around the
world. COVID-19 shows various clinical symptoms (fever, cough, fatigue, diarrhea, body …